Gilead Sciences, Inc. (GILD)

Gilead Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Cash & Equivalents	7,628	7,564	7,330	5,144	7,926	9,991	5,037	2,772	4,718	6,085	5,705	5,704	4,936	5,412	4,699	4,739	4,296	5,338	4,362	4,893
Short-Term Investments	15	68	19	69	-	-	-	-	-	1,179	1,159	963	936	973	961	924	1,029	1,182	1,376	1,632
Cash & Short-Term Investments	7,643	7,632	7,349	5,213	7,926	9,991	5,037	2,772	4,718	7,264	6,864	6,667	5,872	6,385	5,660	5,663	5,325	6,520	5,738	6,525
Cash Growth (YoY)	-3.57%	-23.61%	45.90%	88.06%	68.00%	37.54%	-26.62%	-58.42%	-19.65%	13.77%	21.27%	17.73%	10.27%	-2.07%	-1.36%	-13.21%	-6.02%	-11.99%	-76.07%	-65.50%
Accounts Receivable	4,741	4,913	5,095	4,781	4,388	4,420	4,587	4,663	4,669	4,660	4,790	4,229	4,162	4,777	4,354	4,118	3,787	4,493	4,566	4,149
Inventory	1,914	1,774	1,785	1,825	1,759	1,710	1,869	2,026	1,853	1,787	1,663	1,633	1,576	1,507	1,463	1,494	1,482	1,618	1,676	1,772
Other Current Assets	4,342	4,024	3,645	2,899	2,828	3,052	3,287	2,856	2,800	2,374	2,662	1,757	1,846	1,774	2,077	1,900	2,035	2,141	2,011	1,479
Total Current Assets	18,641	18,342	17,874	14,718	16,901	19,173	14,779	12,317	14,041	16,085	15,980	14,287	13,456	14,443	13,554	13,175	12,629	14,772	13,991	13,925
Net Property, Plant & Equipment	5,638	5,606	5,500	5,459	5,421	5,414	5,391	5,346	5,321	5,317	5,572	5,540	5,479	5,475	5,349	5,299	5,253	5,121	5,037	4,996
Other Intangible Assets	16,382	16,978	17,970	18,566	19,355	19,948	20,546	22,832	23,428	26,454	27,152	27,750	28,348	28,894	29,440	29,885	30,331	33,455	33,900	34,341
Goodwill	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,332	8,332	8,334
Long-Term Investments	983	2,974	2,005	1,913	-	-	-	-	-	1,163	1,156	1,334	1,327	1,245	1,282	1,337	1,427	1,309	1,099	836
Other Long-Term Assets	6,321	6,809	6,871	6,752	6,443	6,147	5,494	4,770	5,188	4,792	4,200	5,113	4,952	4,800	4,618	4,860	5,126	4,963	4,739	5,552
Total Assets	56,278	59,023	58,533	55,721	56,434	58,995	54,525	53,579	56,292	62,125	62,373	62,337	61,876	63,171	62,557	62,870	63,080	67,952	67,098	67,984

Liabilities

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Accounts Payable	645	715	808	582	737	833	903	537	622	550	586	622	627	905	614	565	583	705	585	608
Accrued Expenses	4,118	4,337	4,931	4,215	4,185	3,892	4,113	3,923	4,263	3,802	3,714	3,494	3,477	3,479	3,674	3,519	3,450	3,244	3,368	3,290
Current Portion of Long-Term Debt	1,313	2,807	2,806	2,806	2,806	1,815	1,812	1,810	3,667	1,798	1,793	4,037	2,283	2,273	2,270	1,021	1,025	1,516	2,511	2,261
Other Current Liabilities	3,399	3,953	3,752	3,586	4,615	5,464	4,896	4,510	4,464	5,130	5,852	5,810	4,140	4,580	3,865	4,115	3,500	6,145	3,781	4,055
Total Current Liabilities	9,476	11,813	12,298	11,189	12,344	12,004	11,725	10,781	13,015	11,280	11,945	13,964	10,528	11,237	10,423	9,220	8,558	11,610	10,245	10,214
Long-Term Debt	20,861	22,129	22,135	22,140	22,146	24,896	21,437	21,540	21,527	23,189	23,189	21,209	22,956	22,957	22,953	25,195	25,183	25,179	25,175	27,914
Other Long-Term Liabilities	2,510	2,463	2,645	2,801	2,865	2,849	2,972	3,063	4,295	4,907	4,996	6,070	7,453	7,768	8,124	8,240	9,424	10,099	10,207	10,146
Total Long-Term Liabilities	23,371	24,592	24,780	24,941	25,011	27,745	24,409	24,603	25,822	28,096	28,185	27,279	30,409	30,725	31,077	33,435	34,607	35,278	35,382	38,060
Total Liabilities	32,847	36,405	37,078	36,130	37,355	39,749	36,134	35,384	38,837	39,376	40,130	41,243	40,937	41,962	41,500	42,655	43,165	46,888	45,627	48,274

Shareholders' Equity

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Preferred Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	1
Common Stock	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Additional Paid-in Capital	9,305	8,932	8,678	8,367	8,138	7,700	7,327	7,022	6,813	6,500	6,279	6,008	5,793	5,550	5,226	5,031	4,867	4,661	4,492	4,271
Accumulated Other Comprehensive Income	78	39	36	-18	92	132	73	93	69	28	31	10	-20	2	98	87	73	83	74	39
Retained Earnings	14,131	13,730	12,825	11,325	10,931	11,497	11,073	11,165	10,656	16,304	16,002	15,138	15,223	15,687	15,756	15,117	14,986	16,324	16,903	15,392
Total Common Shareholders' Equity	23,515	22,703	21,540	19,674	19,162	19,330	18,475	18,281	17,539	22,833	22,314	21,158	20,997	21,240	21,081	20,236	19,927	21,069	21,470	19,703
Minority Interest	-84	-84	-84	-84	-84	-84	-84	-84	-84	-84	-72	-64	-58	-31	-24	-21	-12	-5	1	7
Shareholders' Equity	23,431	22,618	21,456	19,590	19,078	19,246	18,390	18,197	17,455	22,749	22,242	21,094	20,939	21,209	21,057	20,215	19,915	21,064	21,471	19,710
Total Liabilities & Equity	56,278	59,023	58,533	55,721	56,434	58,995	54,525	53,579	56,292	62,125	62,373	62,337	61,876	63,171	62,557	62,870	63,080	67,952	67,098	67,984

Additional Metrics

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Total Debt	22,174	24,936	24,941	24,946	24,952	26,711	23,249	23,350	25,194	24,987	24,982	25,246	25,239	25,230	25,223	26,216	26,208	26,695	27,686	30,175
Net Cash (Debt)	-14,531	-17,304	-17,592	-19,733	-17,026	-16,720	-18,212	-20,578	-20,476	-17,723	-18,118	-18,579	-19,367	-18,845	-19,563	-20,553	-20,883	-20,175	-21,948	-23,650
Net Cash Growth (YoY)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Cash Per Share	-11.59	-13.81	-14.03	-15.72	-13.52	-13.28	-14.52	-16.45	-16.42	-14.11	-14.41	-14.77	-15.36	-14.91	-15.51	-16.31	-16.55	-15.99	-17.39	-18.77
Book Value	23,515	22,703	21,540	19,674	19,162	19,330	18,475	18,281	17,539	22,833	22,314	21,158	20,997	21,240	21,081	20,236	19,927	21,069	21,470	19,703
Book Value Per Share	18.75	18.12	17.18	15.68	15.22	15.35	14.73	14.61	14.06	18.18	17.75	16.82	16.65	16.80	16.72	16.06	15.79	16.69	17.01	15.64
Tangible Book Value	-1,181	-2,589	-4,744	-7,206	-8,507	-8,932	-10,385	-12,865	-14,203	-11,935	-13,152	-14,906	-15,665	-15,968	-16,673	-17,963	-18,718	-20,718	-20,762	-22,972
Tangible Book Value Per Share	-0.94	-2.07	-3.78	-5.74	-6.76	-7.09	-8.28	-10.28	-11.39	-9.50	-10.46	-11.85	-12.42	-12.63	-13.22	-14.26	-14.83	-16.42	-16.45	-18.23

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error